PL2865422T3 - Pochodne alfa-MSH do leczenia fotodermatoz - Google Patents

Pochodne alfa-MSH do leczenia fotodermatoz

Info

Publication number: PL2865422T3
Authority: PL; Poland
Prior art keywords: photodermatoses; alpha; treatment; msh derivatives; msh
Prior art date: 2006-08-31

Application number

PL14173509T

Other languages

English (en)

Inventor

Philippe Wolgen

Original Assignee

Clinuvel Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-31

Filing date

2007-08-31

Publication date

2018-01-31

2006-08-31 Priority claimed from AU2006904745A external-priority patent/AU2006904745A0/en

2007-08-31 Application filed by Clinuvel Pharmaceuticals Ltd filed Critical Clinuvel Pharmaceuticals Ltd

2018-01-31 Publication of PL2865422T3 publication Critical patent/PL2865422T3/pl

Links

206010041303 Solar dermatitis Diseases 0.000 title 1
WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Birds (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL14173509T 2006-08-31 2007-08-31 Pochodne alfa-MSH do leczenia fotodermatoz PL2865422T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
AU2006904745A AU2006904745A0 (en)		2006-08-31	Method for Treatment of Photodermatoses
AU2007900862A AU2007900862A0 (en)		2007-02-21	Method for treatment of photodermatoses
EP14173509.2A EP2865422B1 (en)	2006-08-31	2007-08-31	Alpha-MSH derivatives for the treatment of photodermatoses
EP07800234.2A EP2056855B1 (en)	2006-08-31	2007-08-31	Alpha-msh derivatives for the treatment of photodermatoses

Publications (1)

Publication Number	Publication Date
PL2865422T3 true PL2865422T3 (pl)	2018-01-31

Family

ID=39135428

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL07800234T PL2056855T3 (pl)	2006-08-31	2007-08-31	Pochodne alfa-MSH do leczenia fotodermatoz
PL14173509T PL2865422T3 (pl)	2006-08-31	2007-08-31	Pochodne alfa-MSH do leczenia fotodermatoz

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL07800234T PL2056855T3 (pl)	2006-08-31	2007-08-31	Pochodne alfa-MSH do leczenia fotodermatoz

Country Status (16)

Country	Link
US (1)	US8334265B2 (pl)
EP (2)	EP2865422B1 (pl)
AU (1)	AU2007291886B2 (pl)
CA (1)	CA2662163C (pl)
CY (1)	CY1115804T1 (pl)
DK (2)	DK2865422T3 (pl)
ES (2)	ES2646049T3 (pl)
HU (2)	HUE035074T2 (pl)
LU (1)	LUC00062I2 (pl)
NL (1)	NL300926I2 (pl)
NZ (1)	NZ575133A (pl)
PL (2)	PL2056855T3 (pl)
PT (2)	PT2865422T (pl)
SI (2)	SI2865422T1 (pl)
WO (1)	WO2008025094A1 (pl)
ZA (1)	ZA200901364B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008025074A1 (en) *	2006-08-28	2008-03-06	Clinuvel Pharmaceuticals Limited	Method for reducing incidence or rate of development of skin cancers and related conditions
CA2716509A1 (en) *	2008-02-22	2009-08-27	Clinuvel Pharmaceuticals Limited	Method for treatment of photosensitivity and phototoxicity
DK2957292T3 (en)	2008-03-27	2018-01-22	Clinuvel Pharmaceuticals Ltd	VITILIGOTERAPHY
CA2761607C (en)	2009-06-08	2018-09-04	Yi-Qun Shi	Melanocortin receptor-specific peptides
EP2440572B1 (en)	2009-06-08	2017-04-05	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
US8979797B2 (en) *	2010-12-16	2015-03-17	Ams Research Corporation	High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
EP2487185A1 (en) *	2011-02-11	2012-08-15	Clinuvel Pharmaceuticals Limited	Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
US9371555B2 (en)	2012-06-01	2016-06-21	Concordia Laboratories Inc.	Lighting systems and methods of using lighting systems for in vitro potency assay for photofrin
WO2014198890A1 (en) *	2013-06-13	2014-12-18	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical compositions for the treatment of erythropoietic protoporphyria
WO2015063099A1 (en) *	2013-10-28	2015-05-07	Clinuvel Ag	Alpha-msh analogues for use in the treatment of hailey-hailey disease
WO2015063102A1 (en) *	2013-10-28	2015-05-07	Clinuvel Ag	Alpha-msh analogues for use in bullous disease
EP3088417A1 (en)	2015-04-28	2016-11-02	Vallaurix Pte. Ltd.	Pharmaceutical compound
EP3088418A1 (en)	2015-04-28	2016-11-02	Vallaurix Pte. Ltd.	Pharmaceutical compound
ES2985745T3 (es) *	2017-02-01	2024-11-07	Vallaurix Mc S A R L	Análogos de alfa-MSH utilizados en el tratamiento de Xeroderma Pigmentosum
CA3186880A1 (en)	2020-06-10	2021-12-16	Mitsubishi Tanabe Pharma Corporation	Prophylactic or therapeutic agent for porphyria
KR20230016008A (ko)	2020-06-10	2023-01-31	미쓰비시 타나베 파마 코퍼레이션	광선성 피부질환의 예방 또는 치료제
WO2021251450A1 (ja)	2020-06-10	2021-12-16	田辺三菱製薬株式会社	ポルフィリン症の予防又は治療剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4457864A (en)	1981-10-23	1984-07-03	University Patents, Inc.	Synthetic analogues of α-melanotropin
US4485039A (en)	1982-06-11	1984-11-27	University Patents, Inc.	Synthetic analogues of α-melanotropin
ATE84420T1 (de)	1986-02-03	1993-01-15	University Patents Inc	Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
US5674839A (en)	1987-05-22	1997-10-07	Competitive Technologies, Inc.	Cyclic analogs of alpha-MSH fragments
US5049547A (en)	1988-02-11	1991-09-17	University Patents, Inc.	Composition for stimulating integumental melanocytes
US5252318A (en)	1990-06-15	1993-10-12	Allergan, Inc.	Reversible gelation compositions and methods of use
EP0979101B1 (en)	1996-07-03	2010-10-27	Merial, Inc.	Recombinant canine adenovirus 2 (cav2) containing exogenous dna
US5990091A (en)	1997-03-12	1999-11-23	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
IL139637A0 (en)	1998-05-15	2002-02-10	Quark Biotech Inc	Mechanical stress induced genes, expression products therefrom, and uses thereof
AU2003206496B2 (en)	2002-02-26	2007-08-02	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Method of stimulation of melanin production and induction of skin tanning
NZ582130A (en) *	2004-08-04	2011-11-25	Clinuvel Pharmaceuticals Ltd	Methods of inducing melanogenesis in a subject
CA2582607C (en) *	2004-10-08	2016-07-12	Clinuvel Pharmaceuticals Limited	Compositions and methods for inducing melanogenesis in a subject
WO2008025074A1 (en)	2006-08-28	2008-03-06	Clinuvel Pharmaceuticals Limited	Method for reducing incidence or rate of development of skin cancers and related conditions

2007
- 2007-08-31 DK DK14173509.2T patent/DK2865422T3/da active
- 2007-08-31 ES ES14173509.2T patent/ES2646049T3/es active Active
- 2007-08-31 PL PL07800234T patent/PL2056855T3/pl unknown
- 2007-08-31 AU AU2007291886A patent/AU2007291886B2/en active Active
- 2007-08-31 PL PL14173509T patent/PL2865422T3/pl unknown
- 2007-08-31 ZA ZA200901364A patent/ZA200901364B/xx unknown
- 2007-08-31 EP EP14173509.2A patent/EP2865422B1/en active Active
- 2007-08-31 PT PT141735092T patent/PT2865422T/pt unknown
- 2007-08-31 ES ES07800234.2T patent/ES2525476T3/es active Active
- 2007-08-31 CA CA2662163A patent/CA2662163C/en active Active
- 2007-08-31 EP EP07800234.2A patent/EP2056855B1/en active Active
- 2007-08-31 DK DK07800234.2T patent/DK2056855T3/en active
- 2007-08-31 NZ NZ575133A patent/NZ575133A/en not_active IP Right Cessation
- 2007-08-31 SI SI200731978T patent/SI2865422T1/sl unknown
- 2007-08-31 US US12/438,990 patent/US8334265B2/en active Active
- 2007-08-31 HU HUE14173509A patent/HUE035074T2/en unknown
- 2007-08-31 SI SI200731566T patent/SI2056855T1/sl unknown
- 2007-08-31 WO PCT/AU2007/001276 patent/WO2008025094A1/en not_active Ceased
- 2007-08-31 PT PT78002342T patent/PT2056855E/pt unknown
2014
- 2014-12-08 CY CY20141101016T patent/CY1115804T1/el unknown
2018
- 2018-01-31 NL NL300926C patent/NL300926I2/nl unknown
- 2018-02-02 LU LU00062C patent/LUC00062I2/fr unknown
- 2018-02-12 HU HUS1800006C patent/HUS1800006I1/hu unknown

Also Published As

Publication number	Publication date
WO2008025094A1 (en)	2008-03-06
CA2662163C (en)	2015-11-24
US8334265B2 (en)	2012-12-18
US20100120668A1 (en)	2010-05-13
NL300926I2 (nl)	2018-03-20
LUC00062I1 (pl)	2018-02-08
EP2056855A1 (en)	2009-05-13
PT2056855E (pt)	2014-12-12
EP2056855A4 (en)	2013-06-19
AU2007291886B2 (en)	2013-01-10
SI2865422T1 (sl)	2017-12-29
AU2007291886A1 (en)	2008-03-06
ES2646049T3 (es)	2017-12-11
EP2056855B1 (en)	2014-09-17
ES2525476T3 (es)	2014-12-23
EP2865422B1 (en)	2017-10-18
PL2056855T3 (pl)	2015-04-30
DK2865422T3 (da)	2017-11-20
HUE035074T2 (en)	2018-05-02
ZA200901364B (en)	2010-06-30
CA2662163A1 (en)	2008-03-06
HK1130208A1 (en)	2009-12-24
PT2865422T (pt)	2017-11-14
EP2865422A1 (en)	2015-04-29
HUS1800006I1 (hu)	2018-05-02
SI2056855T1 (sl)	2015-01-30
LUC00062I2 (pl)	2018-03-28
DK2056855T3 (en)	2014-12-15
CY1115804T1 (el)	2017-01-25
NZ575133A (en)	2011-11-25

Publication	Publication Date	Title
HUS1800006I1 (hu)	2018-05-02	Alfa-MSH származékok fotodermatózisok kezelésére
ZA200805877B (en)	2009-07-29	Pyridiazinone derivatives for tumour treatment
IL198847A (en)	2015-07-30	Process for making 2-imino-thiazolidine-4-on and several such histories
IL197137A0 (en)	2009-11-18	Tonsillitis treatment
ZA200806072B (en)	2009-04-29	Hydantoin derivatives for the treatment of inflammatory disorders
ZA201001264B (en)	2011-07-27	1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
IL196202A0 (en)	2009-09-22	Indazole derivatives for the treatment of hsp90-induced diseases
ZA200805159B (en)	2009-03-25	Imidazole derivatives for the treatment of gastrointestinal disorders
ZA201007362B (en)	2012-05-30	Conjugates for the treatment of mesothelioma
IL192933A0 (en)	2009-02-11	Benzoisoindole derivatives for the treatment of pain
ZA200904328B (en)	2010-09-29	Prophylactic or therapeutic agent for alopecia
IL226363A0 (en)	2013-06-27	Compounds and methods for treating cancer
PL380561A1 (pl)	2008-03-17	Sposób otrzymywania pochodnych antracyklin
ZA200800921B (en)	2009-06-24	Pyrazolone derivatives for the treatment of tuberculosis
IL194737A0 (en)	2009-08-03	2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
GB0624439D0 (en)	2007-01-17	Technique for treatment of gall-and kidney-stones
GB0602857D0 (en)	2006-03-22	The treatment of sialorrhoea
ZA200806180B (en)	2009-07-29	Benzoisoindole derivatives for the treatment of pain
GB0604114D0 (en)	2006-04-12	Combinations for the treatment of cancer
GB0602858D0 (en)	2006-03-22	The treatment of sialorrhoea
GB0602855D0 (en)	2006-03-22	The Treatment Of Sialorrhoea
ZA200707384B (en)	2008-11-26	Process for the preparation of 1-aminopiperidine derivatives
IL194261A0 (en)	2009-09-22	S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
HK1122032A (en)	2009-05-08	Benzoisoindole derivatives for the treatment of pain
GB0715257D0 (en)	2007-09-12	Phenylthiazolylpiperazine derivatives for the treatment of nuero degenerative diseases